'A good man': Stu Wilson remembered by Tauranga Hospital colleague
It was confirmed today the former captain and winger died peacefully in his sleep over the weekend aged 70.
Regional team leader Bruce Raynel told 1News Wilson joined the Tauranga Hospital orderly team in 2021 following a stint in the hospital related to his heart.
"Stuey, fair dinkum, he wanted a job. He wanted to pay back to some of the heart specialists that saved his life and he thought the best way to do it was to become an orderly," said Raynel.
"We were a bit hesitant to start with because an All Black, in a hospital, people are going to get to know him so he's going to get delayed from bringing jobs back and we're going to be wondering where he is. But old Stuey, he was good.
ADVERTISEMENT
"He would stop and have a quick chat with people, but he'd also say 'no I've got to get to my next job'."
Stu Wilson and Bay of Plenty District Health Board orderly service regional team leader Bruce Raynel in 2021. (Source: Supplied)
Wilson was 'good value'
Raynel described Wilson, who finished up at the hospital late last year, as a good orderly who did what was asked of him, without question and "got on and did the job that he had to do".
"He was good value, and he mixed with everybody. Staff, patients and especially the guys in the lodge."
Rarnel said it was "pretty special" to have hired an All Black.
Wilson controversially retired from rugby while still in his prime after co-authoring the book Ebony and Ivory alongside fellow winger Bernie Fraser, which went against rugby's governing rules at the time.
ADVERTISEMENT
"One of the staff actually said they had the book Ebony and Ivory that him and Bernie Fraser put together. And this person didn't have their book signed, and I had one that wasn't signed as well. And Stuey said, 'well bring them in and I'll send them to Bernie and get him to autograph them for you'."
Little did the staff know Fraser was based in Perth at the time and Wilson had the books sent all the way there to be signed.
Stu Wilson (left) and Bruce Raynel (right) outside Tauranga Hospital. (Source: Supplied)
"It was pretty hard case. Nah he was a good man alright. Good fun having him around."
Donuts, coffee and anecdotes
Raynel shared some other warm memories and personal quirks of Wilson's, including his love of donuts and good quality coffee.
"He's called back a few times for a coffee and a donut. Donuts was his thing. He'd buy donuts on his way home for work. He'd buy three. One for himself on the way home, one for when he got home so one for his wife and one for him.'
ADVERTISEMENT
Raynel said he was particular about his coffee and had his own plunger.
"Stu said at the interview that it wasn't about the money or things like that, he just wanted to give back to an environment that helped him along the way and gave him a few extra years to live after the cardiac problem he had."
Raynel said there were many people who recognised him for his All Black fame - staff and patients alike.
"He didn't want a leadership role with us, because the only time he was ever the leader of the All Blacks, they lost," he laughed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
1News
21 hours ago
- 1News
Australian researchers say psychedelics could benefit terminally ill
Psychedelics could significantly alleviate the anguish, debilitating depression and death-anxiety often experienced by the terminally ill but its implications could be much more profound, clinicians say. In an Australian-first, a near three-year clinical trial examined the use of psilocybin — a naturally occurring compound found in some species of mushrooms — in combination with psychotherapy for dozens of people living with crippling, life-threatening illness. Psychologist Margaret Ross and psychiatrist Dr Justin Dwyer, who co-led the study, said the drug was able to ease the debilitating death-related anxiety and depression experienced by many palliative care patients. "When you're told you're going to die, your entire world collapses... it's the final unknowable frontier," Dwyer told AAP. "Many people find themselves stranded in this endless moment of waiting to die, just waiting for the axe to fall... with that, comes crushing feelings of despair." ADVERTISEMENT There are few treatments available for people experiencing distress around dying. Between January 2020 and October 2023, 35 terminally ill participants were given psilocybin over two eight-hour treatment sessions several weeks apart at St Vincent's Hospital in Melbourne. Both sessions were accompanied by nine psychotherapy sessions before and after dosing. The trial's findings have been published in General Hospital Psychiatry. A Gisborne-based company is pioneering research into psychoactive compounds that could alter brain receptors and prompt positive behavioural changes. (Source: 1News) Those in the study reported significant reductions in depression and anxiety as well as sustained gains in mood, outlook, and wellbeing within 24 hours of treatment. But Dwyer said these results only touched the surface. ADVERTISEMENT "Many patients reported having a transformational experience," he said. "They felt they had a sense of being back in life in a richer, more vibrant way. "One patient said they felt saturated with a divinity that wasn't there before." While results were promising, the clinicians emphasised psychedelic-assisted therapy was still in its early stages. "It didn't work for everyone," Dwyer cautioned. "And it shouldn't be a treatment open slather for all." Melbourne psychiatrist Eli Kotler was among a handful of Australian doctors able to prescribe psychedelic medication and agreed the treatment needed to be used cautiously. ADVERTISEMENT Kotler said psychedelics such as psilocybin helped with human suffering, a condition he believed was at the heart of the St Vincent's study for those confronting dying. "In many ways, mental health has lost it's heart and soul and runs the risk of treating psychiatric diagnoses rather than helping humans heal," he told AAP. Psilocybin appeared to work by changing the way parts of the brain connected and interacted. Dwyer said there were theories but nobody really knew how the drug worked. In recent years, there has been an explosion of interest in the therapeutic effects of psilocybin, with half-a-dozen studies underway in Australia, and many more in the pipeline. Psilocybin and MDMA have been able to be prescribed by approved psychiatrists for certain mental health conditions since July of 2023.
1News
14-08-2025
- 1News
Philip Polkinghorne may give evidence at inquest into wife's death
The Auckland eye surgeon found not guilty of killing his wife after a lengthy murder trial last year may give evidence at her coronial inquest next year. Pauline Hanna, who managed the rollout of the Covid-19 vaccine as an executive director at Counties Manukau Health, died in her Remuera home on April 5, 2021. Her husband, former Auckland eye surgeon Philip Polkinghorne, was found not guilty of her murder after an eight-week trial. A pre-hearing conference has taken place in the North Shore District Court this morning with a number of key figures from the trial appearing in court once again. Polkinghorne and his lawyer Ron Mansfield were present, alongside Pauline's brother Bruce Hanna, and niece Rose, and lawyer Alysha McClintock representing the police. ADVERTISEMENT There was also a large media presence, including author Steve Braunias who has written a book about the trial, Polkinghorne, and documentary maker Mark McNeill. Coroner Tania Tetitaha laid out a timeline for lawyers to produce evidence for the inquest. She gave them 28 days to come up with agreed facts and contested evidence. The coroner asked if Polkinghorne would be available to appear before the inquest in August next year. Philip Polkinghorne leaves the North Shore District Court. (Source: 1News) Mansfield said Polkinghorne could make himself available. She deemed it relevant, saying he would know best the stressors in her life leading up to Hanna's death, as her husband. ADVERTISEMENT Mansfield raised concerns around how far back evidence would be collected for the inquest, calling a submission filed by the police a "pseudo-prosecution" of Polkinghorne. "The main issue is going to be what happened on that evening, I have no doubt about that," Tetitaha said. It was revealed in July Australian sex worker Madison Ashton, Polkinghorne's former lover, had asked to give evidence at the inquest. Tetitaha brought up Asthon's potential evidence, saying it would be useful to hear from Polkinghorne on what was presented. The Crown argued during his criminal trial held in the High Court at Auckland Polkinghorne killed his wife after a possible violent struggle, while he may have been under the influence of methamphetamine. His defence maintained Hanna died by suicide after many years of struggling with depression, compounded by work-related stress. The inquest is expected to get underway in August 2026. ADVERTISEMENT
1News
07-08-2025
- 1News
New mRNA vaccines saved millions — so why is the US pulling funding?
So-called mRNA vaccines saved millions of lives during the Covid-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and treatments against a long list of diseases including cancer and cystic fibrosis. But this week, US Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic, cancelled US$500 million (NZ$842 million) in government-funded research projects to create new mRNA vaccines against respiratory illnesses that might trigger another health emergency. That dismays infectious disease experts who note that mRNA allows faster production of shots than older vaccine-production methods, buying precious time if another pandemic were to emerge. Using older technology to target a pandemic flu strain would take 18 months to 'make enough vaccine to vaccinate only about one-fourth of the world", said Michael Osterholm of the University of Minnesota, an expert on pandemic preparation. But using mRNA technology 'could change that dramatically, such that by the end of the first year, we could vaccinate the world'. How mRNA technology works ADVERTISEMENT Traditionally, making vaccines required growing viruses or pieces of viruses called proteins — often in giant vats of cells or, like most flu shots, in chicken eggs — and then purifying them. Injecting a small dose as a vaccine trains the body how to recognize when a real infection hits so it's ready to fight back. But that technology takes a long time. Using mRNA is a faster process. The 'm' stands for messenger, meaning mRNA carries instructions for our bodies to make proteins. Scientists figured out how to harness that natural process by making mRNA in a lab. They take a snippet of that genetic code that carries instructions for making the protein they want the vaccine to target. Injecting that snippet instructs the body to become its own mini-vaccine factory, making enough copies of the protein for the immune system to recognise and react. The morning's headlines in 90 seconds, including a cold weekend on the way, Israel reveals a new plan in Gaza, and what not do when driving over a rail crossing. (Source: 1News) The Covid-19 vaccines aren't perfect Years of research show protection from Covid-19 vaccines — both the types made with mRNA and a type made with traditional technology — does wane over time. The vaccinations provide the strongest protection against severe infection and death, even if people still become infected. ADVERTISEMENT But that's a common feature with both the coronavirus and flu because both viruses continually mutate. That's the reason we're told to get a flu vaccine every year — using vaccines made with traditional methods, not mRNA. Today's Covid-19 vaccines made with mRNA by Pfizer and Moderna can be updated more quickly each year than traditional types, an advantage that now has multiple companies developing other vaccines using the technology. Traditional vaccines aren't the only use for mRNA Osterholm counts about 15 infectious disease vaccines that could benefit from mRNA technology, but that's not the only potential. Many disease therapies take aim at proteins, making mRNA a potential technique for developing new treatments. Researchers already are testing an mRNA-based therapeutic vaccine for pancreatic cancer. Genetic diseases are another target, such as an experimental inhaled therapy for cystic fibrosis.
